1. Home
  2. UCAR vs ACON Comparison

UCAR vs ACON Comparison

Compare UCAR & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

N/A

Current Price

$3.28

Market Cap

6.9M

ML Signal

N/A

Logo Aclarion Inc.

ACON

Aclarion Inc.

N/A

Current Price

$1.99

Market Cap

6.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
UCAR
ACON
Founded
2013
2008
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
6.6M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
UCAR
ACON
Price
$3.28
$1.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
★ 34.7K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.82
EPS
★ N/A
N/A
Revenue
N/A
★ $75,730.00
Revenue This Year
N/A
$44.55
Revenue Next Year
$13.33
$123.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 65.62
52 Week Low
$0.04
$1.85
52 Week High
$8.99
$9.36

Technical Indicators

Market Signals
Indicator
UCAR
ACON
Relative Strength Index (RSI) 43.46 34.87
Support Level $1.05 N/A
Resistance Level $4.19 $3.54
Average True Range (ATR) 0.19 0.10
MACD -0.15 -0.03
Stochastic Oscillator 3.49 15.18

Price Performance

Historical Comparison
UCAR
ACON

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: